The Assessment of the Innovativeness of a New Medicine in Italy

The Assessment of the Innovativeness of a New Medicine in Italy

Objectives: Starting from April 2017, the Italian Medicine Agency (AIFA) has approved new criteria for defining any new medicinal product with an innovative indication. The purpose of the study is to analyze the activity of innovativeness evaluation according to the new approach, to estimate the wei...

Full description

Bibliographic Details
Main Authors: Filomena Fortinguerra, Serena Perna, Roberto Marini, Alessandra Dell'Utri, Maurizio Trapanese, Francesco Trotta, Scientific & Technical Committee (Commissione Tecnico-Scientifica, CTS) of Italian Medicines Agency-AIFA
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-12-01
Series:Frontiers in Medicine
Subjects:
innovativeness
drug therapy
therapeutic need
added therapeutic value
grade
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2021.793640/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2021.793640/full

Similar Items